
Sifting Through Senior-Loken Syndrome 9: Genetic Testing as a Guiding Light
Care is shared between nephrologists, ophthalmologists and geneticists for this nephronophthisis-related ciliopathy, which has been linked to NPHP1 and other genes.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Care is shared between nephrologists, ophthalmologists and geneticists for this nephronophthisis-related ciliopathy, which has been linked to NPHP1 and other genes.

Marked muscle weakness, delayed motor and cognitive milestones, misaligned eyes and heart septal defects occur together in a syndrome genetic testing can pin down.

Intellectual disability, a missing corpus callosum, facial differences and cerebellar ataxia define this syndrome, and testing can confirm it and clarify recurrence risk.

Iron-loaded mitochondria in immature red cells signal sideroblastic anemia 3, where ALAS2 variants disturb heme synthesis; a synonymous change can alter mRNA splicing.

A PDGFRB mutation reported in Kosaki overgrowth syndrome sits behind this rare mix of skeletal overgrowth, hyperelastic skin and white matter lesions.

Symmetrical creases encircling the body from birth define CSCSC2, and a de novo variant in the MAPRE2 gene has been identified as a cause of the disorder.

Mutations in SLC39A8 disrupt manganese transport and glycosylation, leading to developmental delay and movement disorders; galactose and manganese studies are covered.

Severe developmental delay, epilepsy and spastic paraplegia define this rare syndrome, which may also involve ocular abnormalities, incontinence and hearing loss.